We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNRH
501
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$19.5M 0.04%
1,988,430
VAQC
502
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$19.5M 0.04%
2,000,101
PDOT
503
DELISTED
Peridot Acquisition Corp. II
PDOT
$19.4M 0.04%
1,985,007
PNR icon
504
Pentair
PNR
$10.2B
$19.4M 0.04%
357,357
+15,569
+5% +$942K
VICI icon
505
VICI Properties
VICI
$29.4B
$19.4M 0.04%
680,257
+660,517
+3,346% +$18.5M
ACVA icon
506
ACV Auctions
ACVA
$1.35B
$19.2M 0.04%
1,299,390
+562,246
+76% +$7.82M
H icon
507
Hyatt Hotels
H
$17.6B
$19.2M 0.04%
201,600
-162,900
-45% -$15.3M
LEG icon
508
Leggett & Platt
LEG
$1.52B
$19.2M 0.04%
551,517
+530,596
+2,536% +$20.3M
BALL icon
509
Ball Corp
BALL
$17B
$19.1M 0.04%
212,527
+181,930
+595% +$16.5M
BEKE icon
510
KE Holdings
BEKE
$16.8B
$19.1M 0.04%
+1,545,137
New +$27.5M
ZS icon
511
Zscaler
ZS
$23B
$19.1M 0.04%
79,133
+2,667
+3% +$655K
SEDG icon
512
SolarEdge
SEDG
$2.59B
$19M 0.04%
59,054
+35,889
+155% +$9.86M
JOFF
513
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
$19M 0.04%
1,944,643
JPM icon
514
CALL
JPMorgan Chase
JPM
$939B
$19M 0.04%
139,300
+85,400
+158% +$12.6M
MU icon
515
CALL
Micron Technology
MU
$1.04T
$19M 0.04%
243,400
-63,700
-21% -$5.43M
FINM
516
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$18.8M 0.04%
1,913,169
ELIQ
517
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$18.7M 0.04%
1,908,080
AAQC
518
DELISTED
Accelerate Acquisition Corp
AAQC
$18.6M 0.04%
1,908,797
MBAC
519
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
$18.6M 0.04%
1,899,055
CFIV
520
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$18.5M 0.04%
1,891,320
TGNA
521
DELISTED
TEGNA Inc
TGNA
$18.4M 0.03%
822,406
+683,896
+494% +$14.4M
VVV icon
522
Valvoline
VVV
$4.97B
$18.4M 0.03%
583,718
+574,979
+6,579% +$18.8M
ANF icon
523
Abercrombie & Fitch
ANF
$4.17B
$18.3M 0.03%
573,515
+351,904
+159% +$12.2M
NAAC
524
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$18.3M 0.03%
1,856,129
GROV icon
525
Grove Collaborative
GROV
$45M
$18.3M 0.03%
371,107
+7,968
+2% +$393K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.